13F manager/SUPN/

Robert Bruce (Bruce & Co) add Supernus Pharmaceuticals, Inc.

Robert Bruce (Bruce & Co) add $3.0M of disclosed value in Supernus Pharmaceuticals, Inc..

Signal
Investor Move
Action
Add
Capital
$3.0M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence